Molecular Partners AG (SWX:MOLN)
Switzerland · Delayed Price · Currency is CHF 2.845
-0.035 (-1.22%)
Sep 30, 2025, 4:22 PM CET
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of 107.69 million as of September 30, 2025. Its market cap has decreased by -32.34% in one year.
Market Cap
107.69M
Enterprise Value
-4.96M
Revenue
681.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
2.85
Market Cap Chart
Since November 4, 2014, Molecular Partners AG's market cap has decreased from 426.07M to 107.69M, a decrease of -74.72%. That is a compound annual growth rate of -11.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2025 | 107.69M | -28.05% |
| Dec 30, 2024 | 149.66M | 32.42% |
| Dec 29, 2023 | 113.02M | -43.62% |
| Dec 30, 2022 | 200.48M | -65.16% |
| Dec 30, 2021 | 575.43M | -4.85% |
| Dec 30, 2020 | 604.78M | 60.28% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 219.71B |
| Novartis AG | 191.75B |
| Lonza Group AG | 36.51B |
| Galderma Group AG | 32.36B |
| Alcon | 29.19B |
| Sandoz Group AG | 20.46B |
| Straumann Holding AG | 13.91B |
| Sonova Holding AG | 13.17B |